Recent Updates
Recently added Catalysts
BLFS Positive Sentiment

BioLife Solutions to Report Second Quarter 2025 Financial Results and Business Update on August 7, 2025

Thursday, July 24, 2025 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: BioLife Solutions, Inc. will release its second quarter 2025 financial results on August 7, 2025, after market close. The company will also host a conference call and live webcast at 4:30 PM ET to discuss the results and provide a business update. Investors can access the call through the company's website or by phone.
Price reaction · baseline $22.26 (2025-07-24 close) · hit after-hours · 1 other BLFS headline(s) in the window, move may be shared
day 0 close · peak
+1.4%

Market Sentiment Analysis

POSITIVE FACTORS

  • BioLife Solutions is a leading developer in the CGT market.
  • The upcoming financial results indicate transparency and engagement with investors.
  • The company is actively communicating its business updates.

Full Press Release Details

BOTHELL, Wash.,July 24, 2025/PRNewswire/ --BioLife Solutions, Inc. (NASDAQ:BLFS), a leading developer and supplier of bioproduction products and services for the cell and gene therapy ("CGT") market, today announced the Company's second quarter 2025 financial results will be released after market close onThursday, August 7, 2025. The Company will host a conference call and live webcast at4:30pm ET(1:30pm PT) that day. Management will provide an overview of the Company's financial results and give a general business update.
To access the webcast, log onto the Investor Relations page of the BioLife Solutions website athttps://www.biolifesolutions.com/earnings.In addition, the conference call will be accessible by dialing toll-free 1-833-630-0431 or 1-412-317-1808 for international callers.  A webcast replay will be available approximately two hours after the call and will be archived onhttps://investors.biolifesolutions.com/for 90 days.

About BioLife SolutionsBioLife Solutions is a leading developer and supplier of bioproduction products and services for the cell and gene therapy (CGT) and broader biopharma markets. Our expertise facilitates the commercialization of new therapies by supplying solutions that maintain the health and function of biologic materials during collection, development, storage, and distribution. For more information, please visitwww.biolifesolutions.comor follow BioLife onLinkedInandX.

Media & Investor Relations

Frequently Asked Questions

When will BioLife Solutions report its Q2 2025 results?

BioLife Solutions will report its Q2 2025 financial results on August 7, 2025.

What time is the conference call for Q2 2025 results?

The conference call will take place at 4:30 PM ET on August 7, 2025.

How can I access the BioLife Solutions conference call?

You can access the call via the Investor Relations page on their website or by phone.

Will there be a replay of the conference call?

Yes, a replay will be available approximately two hours after the call.

ShareAdd on Google
Tags: BLFS Viatris Investor Conferences Healthcare BioLife Solutions financial results conference call cell and gene therapy
Last updated: Jul 24, 2025

Biotech snapshot

Cash runway
$81M liquidity · $0M/mo burn
~491 mo
Low dilution risk